2’,4’‐LNA‐Functionalized 5′‐S‐Phosphorothioester CDNs as STING Agonists

Abstract

AbstractCyclic dinucleotides (CDNs) have garnered popularity over the last decade as immunotherapeutic agents, which activate the cyclic GMP‐AMP synthase‐stimulator of interferon genes (cGAS‐STING) pathway to trigger an immune response. Many analogs of 2’3’‐cGAMP, c‐di‐GMP, and c‐di‐AMP have been developed and shown as effective cancer vaccines and immunomodulators for the induction of both the adaptive and innate immune systems. Unfortunately, the effectiveness of these CDNs is limited by their chemical and enzymatic instability. We recently introduced 5’‐endo‐phosphorothoiate 2’3’‐cGAMP analogs as potent STING agonist with improved resistance to cleavage by clinically relevant phosphodiesterases. We herein report the synthesis of locked nucleic acid‐functionalized (LNA) endo‐S‐CDNs and evaluate their ability to activate STING in THP1 monocytes. Interestingly, some of our synthesized LNA 3’3’‐endo‐S‐CDNs can moderately activate hSTING REF haplotype (R232H), which exhibit diminished response to both 2’3’‐cGAMP and ADU‐S100. Also, we show that one of our most potent endo‐S‐CDNs has remarkable chemical (oxidants I2 and H2O2) and phosphodiesterase stability.